Back to search

Article

The Black Hole: CAR T cell Therapy in AML

2023-04-18

Abstract excerpt

Despite exhaustive studies, researchers have made little progress in the field of adoptive cellular therapies for relapsed-refractory acute myeloid leukemia (AML), unlike the notable uptake for B cell malignancies. Various single antigen targeting chimeric antigen receptor (CAR) T cell Phase I trials have been established worldwide and have recruited approximately 100 patients. The high heterogeneity at the geneti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
713d2052-15b4-503b-988c-ad1c032091d2
DOI
10.20944/preprints202304.0482.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Black Hole: CAR T cell Therapy in AMLDOI 10.20944/preprints202304.0482.v1
The Black Hole: CAR T Cell Therapy in AMLSemantic proximity
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatmentSemantic proximity
The cellular state space of AML unveils novel <i>NPM1</i> subtypes with distinct clinical outcomes and immune evasion propertiesSemantic proximity
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemiaSemantic proximity
Novel therapies in AML: reason for hope or just hype?Semantic proximity
Harnessing the Transcriptional Signatures of Car-T Cells and Leukemia/Lymphoma Using Single-Cell Sequencing TechnologiesSemantic proximity
Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting ChallengesSemantic proximity
How to drug a leukemic stem cell: deciphering heterogeneity for better specificitySemantic proximity
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia.Semantic proximity
How close are we to CAR T-cell therapy for AML?Semantic proximity
Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencingSemantic proximity
Single-cell genomics in AML: extending the frontiers of AML researchSemantic proximity
Select a neighboring publication to make it the new centre.